Saturday, July 11, 2026

pharma · Metastatic Breast Cancer · Talaromycosis

Duke University

Duke University clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
2
Drugs
5
Patents
0
Intelligence · Clinical Programs

Duke University projects

1 ClinicalTrials.gov programs sponsored by Duke University.

Duke University has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Liposomal Amphotericin B (LAmB)

    Duke University

    Talaromycosis

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Duke University have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.